These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7529788

  • 21. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J, Rola-Pleszczynski M.
    J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
    [Abstract] [Full Text] [Related]

  • 22. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W, Lynch DH, Starling GC, Kiener PA.
    J Immunol; 1998 Oct 01; 161(7):3292-8. PubMed ID: 9759844
    [Abstract] [Full Text] [Related]

  • 23. Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation.
    Novelli F, Giovarelli M, Reber-Liske R, Virgallita G, Garotta G, Forni G.
    J Immunol; 1991 Aug 15; 147(4):1445-52. PubMed ID: 1831225
    [Abstract] [Full Text] [Related]

  • 24. Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.
    Kuge S, Miura Y, Nakamura Y, Mitomi T, Habu S, Nishimura T.
    J Immunol; 1995 Feb 15; 154(4):1777-85. PubMed ID: 7836762
    [Abstract] [Full Text] [Related]

  • 25. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ, Cameron C, Lazo S, Cochran KJ, Voss SD, Ritz J.
    Nat Immun; 1995 Feb 15; 15(5):213-26. PubMed ID: 9390270
    [Abstract] [Full Text] [Related]

  • 26. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S, Yamano Y, Osame M, Hall WW.
    Cell Immunol; 1996 Nov 01; 173(2):312-6. PubMed ID: 8912892
    [Abstract] [Full Text] [Related]

  • 27. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R, Panka DJ, Wang JK, Stanger BZ, Ju ST, Marshak-Rothstein A.
    J Immunol; 1995 May 01; 154(9):4302-8. PubMed ID: 7536768
    [Abstract] [Full Text] [Related]

  • 28. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
    Kelly-Rogers J, Madrigal-Estebas L, O'Connor T, Doherty DG.
    Hum Immunol; 2006 Nov 01; 67(11):863-73. PubMed ID: 17145366
    [Abstract] [Full Text] [Related]

  • 29. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Nov 01; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 30. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
    Yu CR, Kirken RA, Malabarba MG, Young HA, Ortaldo JR.
    J Immunol; 1998 Jul 01; 161(1):218-27. PubMed ID: 9647227
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 01; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH.
    J Immunol; 1986 May 15; 136(10):3636-42. PubMed ID: 3009608
    [Abstract] [Full Text] [Related]

  • 38. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW, Mikovits JA, Kalyanaraman VS, Overton R, Stevenson H, Stromberg K, Herberman RB, Farrar WL, Ortaldo JR.
    J Immunol; 1986 May 15; 136(10):3619-24. PubMed ID: 2422259
    [Abstract] [Full Text] [Related]

  • 39. Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum.
    McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, de Mast Q, Dolo A, Doumbo OK, Luty A, van der Ven AJ, Hermsen CC, Sauerwein RW.
    Eur J Immunol; 2010 Dec 15; 40(12):3472-7. PubMed ID: 21072880
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 15; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.